The National Cancer Institute funds cancer epidemiology cohort research on cancer causes and survivorship, including cohort upkeep, follow-up, and data and biospecimen sharing; clinical trials are not allowed.
This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.
Funding opportunity for cancer research innovations in statistical methods, epidemiology, survivorship, behaviors, healthcare, and implementation.
Funding available for basic research on biological/genetic causes of cancer health disparities to support innovative studies and enhance expertise in the field.
Facilitates well-planned cancer prevention and control clinical trials by addressing information gaps to improve trial design and feasibility, saving time and money for NCI.
NIH supports investigator-initiated observational or biomarker validation studies requiring prospective collection or continued analysis of data or biospecimens; clinical trials are not allowed.